INSIDERFilingvia Quantisnow
CohBar Inc. logo

CohBar (CWBR) director Amatruda received 200,000 Stock Option (Right to buy)

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

John Amatruda (director at CohBar Inc., CWBR) reported that they received 200,000 Stock Option (Right to buy) on Jun 16, 2021.

Reporting person
Amatruda John

Options and other derivatives

Options and other derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Jun 16, 2021Grant or award (A)Stock Option (Right to buy)On 200,000 Common Stock1+200,000--200,000 direct

Holdings before and after

  • Stock Option (Right to buy): 0 to 200,000 direct

Footnotes from the filing

  1. 1. Shares subject to the option shall vest over 48 successive equal installments (rounded down to the nearest whole share, except for the last vesting installment) beginning June 16, 2021.

Transaction codes in this filing

Grant or award:
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

FAQ

What did Amatruda report in this CWBR Form 4?

John Amatruda (director at CohBar Inc., CWBR) reported that they received 200,000 Stock Option (Right to buy) on Jun 16, 2021.

What does transaction code A mean on an SEC Form 4?

Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

Historical context for CWBR

Earlier insider filings at CWBR

Keep researching CWBR

Quantisnow market dataNASDAQ
CohBar Inc. logo
CWBR
CohBar Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Get push alerts for CWBR

Follow CWBR and get a push notification the moment its next story breaks.

Full CWBR profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CWBR (CohBar Inc.) and more on Quantisnow.